The Use of Antidepressants in Patients with Heart Failure

© 2020 Saudi Heart Association.

Détails bibliographiques
Publié dans:Journal of the Saudi Heart Association. - 1999. - 32(2020), 1 vom: 09., Seite 46-51
Auteur principal: Alsumih, Norah (Auteur)
Autres auteurs: Alqahtani, Rahaf, Almutairi, Faisal, Faraj, Rakan, Alsubeai, Turki, Alghanim, Ahmed, Alharbi, Shmylan, Almodaimegh, Hind
Format: Article en ligne
Langue:English
Publié: 2020
Accès à la collection:Journal of the Saudi Heart Association
Sujets:Journal Article Antidepressants Depression Heart failure Quality of life Selective serotonin uptake inhibitors
LEADER 01000caa a22002652c 4500
001 NLM317230131
003 DE-627
005 20250228080605.0
007 cr uuu---uuuuu
008 231225s2020 xx |||||o 00| ||eng c
024 7 |a 10.37616/2212-5043.1008  |2 doi 
028 5 2 |a pubmed25n1057.xml 
035 |a (DE-627)NLM317230131 
035 |a (NLM)33154891 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
100 1 |a Alsumih, Norah  |e verfasserin  |4 aut 
245 1 4 |a The Use of Antidepressants in Patients with Heart Failure 
264 1 |c 2020 
336 |a Text  |b txt  |2 rdacontent 
337 |a ƒaComputermedien  |b c  |2 rdamedia 
338 |a ƒa Online-Ressource  |b cr  |2 rdacarrier 
500 |a Date Revised 18.04.2022 
500 |a published: Electronic-eCollection 
500 |a Citation Status PubMed-not-MEDLINE 
520 |a © 2020 Saudi Heart Association. 
520 |a BACKGROUND: Heart failure (HF) is a chronic disease affecting patients' quality of life (QoL) and may cause depression. Recent studies reported that the prevalence of depression in patients with HF is 21.5%. Antidepressants, mainly selective serotonin reuptake inhibitors, are usually prescribed for HF patients diagnosed with depression. Some evidence supports antidepressant's role in improving symptoms by enhancing the psychological aspect of their QoL. Depression screening and treatment are important in the multidisciplinary management; however, their survival benefits are inconsistent. In our study, we aim to investigate the prevalence of depression and the use of antidepressants in patients with HF as well as to determine the acceptance of using antidepressants in such patients 
520 |a METHODS: This is a cross-sectional study conducted by interviewing HF outpatients at National Guard Hospital in Riyadh. Patients were assessed using Hamilton depression rating scale 
520 |a RESULTS: A total of 306 patients were included, with the majority (69%) being male and aged >61 years (60%). Patients' medical history was classified into different groups, with the largest proportion (39.9%) in the diabetic-hypertensive group, followed by a diabetic group (21.2%) and a hypertensive group (10.8%). Patients were classified according to the New York Heart Association Functional Classification, and most patients were in Class I (61.8%). Some of the patients (8.5%) had been diagnosed with depression. There was no statistically significant association between HF and depression (p > 0.05). However, 5.6% of patients had been prescribed antidepressants and 17.1% of patients believed that they required antidepressants. Moreover, there was a statically significant association between medical history and development of depression (p = 0.014) 
520 |a CONCLUSIONS: The prevalence of depression in HF patients in our population was lower than reported. There was no association between HF stage, depression, and antidepressant use 
650 4 |a Journal Article 
650 4 |a Antidepressants 
650 4 |a Depression 
650 4 |a Heart failure 
650 4 |a Quality of life 
650 4 |a Selective serotonin uptake inhibitors 
700 1 |a Alqahtani, Rahaf  |e verfasserin  |4 aut 
700 1 |a Almutairi, Faisal  |e verfasserin  |4 aut 
700 1 |a Faraj, Rakan  |e verfasserin  |4 aut 
700 1 |a Alsubeai, Turki  |e verfasserin  |4 aut 
700 1 |a Alghanim, Ahmed  |e verfasserin  |4 aut 
700 1 |a Alharbi, Shmylan  |e verfasserin  |4 aut 
700 1 |a Almodaimegh, Hind  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Journal of the Saudi Heart Association  |d 1999  |g 32(2020), 1 vom: 09., Seite 46-51  |w (DE-627)NLM098225227  |x 1016-7315  |7 nnas 
773 1 8 |g volume:32  |g year:2020  |g number:1  |g day:09  |g pages:46-51 
856 4 0 |u http://dx.doi.org/10.37616/2212-5043.1008  |3 Volltext 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 32  |j 2020  |e 1  |b 09  |h 46-51